Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alen, M. |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A.H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y.A. |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P. |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J. |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S. |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T. |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Rämet, M(ika) |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ruskoaho, H. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Tjäderhane, L. |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds
|
| | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. | Winqvist, R(obert) | 121 days | save |  |  |  | |
| Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. | Winqvist, R(obert) | 199 days | save | | | | |
| A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. | Winqvist, R(obert) | 244 days | save | | | | |
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. | Winqvist, R(obert) | 253 days | save | | | | |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. | Winqvist, R(obert) | 276 days | save | | | | |
| Evaluating the role of MLH3 p.Ser1188Ter variant in inherited breast cancer predisposition. | Winqvist, R(obert) | 316 days | save | | | | |
| BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrier cells. | Winqvist, R(obert) | 333 days | save | | | | |
| Homologous recombination DNA repair defects in PALB2-associated breast cancers. | Winqvist, R(obert) | 394 days | save | | | | |
| Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. | Winqvist, R(obert) | 520 days | save | | | | |
| Genome-wide association study of germline variants and breast cancer-specific mortality. | Winqvist, R(obert) | 573 days | save | | | | |
| Shared heritability and functional enrichment across six solid cancers. | Winqvist, R(obert) | 600 days | save | | | | |
| Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. | Winqvist, R(obert) | 640 days | save | | | | |
| Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls. | Winqvist, R(obert) | 744 days | save | | | | |
| A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. | Winqvist, R(obert) | 821 days | save | | | | |
| The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. | Winqvist, R(obert) | 940 days | save | | | | |
| Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer. | Winqvist, R(obert) | 974 days | save | | | | |
| PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. | Winqvist, R(obert) | 1001 days | save | | | | |
| Body mass index and breast cancer survival: a Mendelian randomization analysis. | Winqvist, R(obert) | 1010 days | save | | | | |
| Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. | Winqvist, R(obert) | 1044 days | save | | | | |
| Association analysis identifies 65 new breast cancer risk loci. | Winqvist, R(obert) | 1060 days | save | | | | |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. | Winqvist, R(obert) | 1060 days | save | | | | |
| FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population. | Winqvist, R(obert) | 1162 days | save | | | | |
| Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. | Winqvist, R(obert) | 1242 days | save | | | | |
| Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility. | Winqvist, R(obert) | 1259 days | save | | | | |
| BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. | Winqvist, R(obert) | 1286 days | save | | | | |
| rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. | Winqvist, R(obert) | 1402 days | save | | | | |
| Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. | Winqvist, R(obert) | 1419 days | save | | | | |
| Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium. | Winqvist, R(obert) | 1441 days | save | | | | |
| Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. | Winqvist, R(obert) | 1459 days | save | | | | |
| Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. | Winqvist, R(obert) | 1471 days | save | | | | |
| Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). | Winqvist, R(obert) | 1471 days | save | | | | |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. | Winqvist, R(obert) | 1472 days | save | | | | |
| Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. | Winqvist, R(obert) | 1485 days | save | | | | |
| Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. | Winqvist, R(obert) | 1486 days | save | | | | |
| FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome. | Winqvist, R(obert) | 1489 days | save | | | | |
| Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. | Winqvist, R(obert) | 1509 days | save | | | | |
| Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. | Winqvist, R(obert) | 1521 days | save | | | | |
| An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. | Winqvist, R(obert) | 1528 days | save | | | | |
| RAD51B in Familial Breast Cancer. | Winqvist, R(obert) | 1596 days | save | | | | |
| Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. | Winqvist, R(obert) | 1604 days | save | | | | |
| Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. | Winqvist, R(obert) | 1613 days | save | | | | |
| Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. | Winqvist, R(obert) | 1624 days | save | | | | |
| Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. | Winqvist, R(obert) | 1661 days | save | | | | |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. | Winqvist, R(obert) | 1664 days | save | | | | |
| Genetic predisposition to ductal carcinoma in situ of the breast. | Winqvist, R(obert) | 1674 days | save | | | | |
| Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility. | Winqvist, R(obert) | 1694 days | save | | | | |
| Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients. | Winqvist, R(obert) | 1746 days | save | | | | |
| Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. | Winqvist, R(obert) | 1752 days | save | | | | |
| BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. | Winqvist, R(obert) | 1763 days | save | | | | |
| Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. | Winqvist, R(obert) | 1816 days | save | | | | |
| | 
report | next » | | |
|
